Daniela Alves Salazar1,2,3, Maria João Silva Ferreira4,5,6, João Sérgio Neves4,5,6, Jorge Manuel Pires Pedro4,5,6, Vanessa Alexandra Guerreiro4,5,6, Sara E Silva Viana7, Fernando Mendonça4,5,6, Maria Manuel Silva4,5,6, Sandra Patrícia Belo4, Ana Varela Sande4,5,6, Paula Freitas4,5,6, David Maurício Carvalho4,5,6. 1. Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal. cdasalazar@gmail.com. 2. Faculty of Medicine, University of Porto, Porto, Portugal. cdasalazar@gmail.com. 3. Institute for Research and Innovation in Health, University of Porto, Porto, Portugal. cdasalazar@gmail.com. 4. Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal. 5. Faculty of Medicine, University of Porto, Porto, Portugal. 6. Institute for Research and Innovation in Health, University of Porto, Porto, Portugal. 7. Department of Internal Medicine of Unidade Local de Saúde do Norte Alentejano Multidisciplinary Group for Surgical Management of Obesity, Centro Hospitalar Universitário de São João, Porto, Portugal.
Abstract
BACKGROUND: Serum 25-hydroxyvitamin D [25(OH)D] and parathormone (PTH) have an inverse relation. The 25(OH)D threshold required to maximally suppress PTH has been used as a marker of optimal vitamin D status. Obesity is associated with lower serum levels of 25(OH)D and higher levels of PTH; however, the relation between these hormones in this setting is not well established. We aimed to assess the influence of excessive weight and weight loss after bariatric surgery on the relation between serum 25(OH)D and PTH. METHODS: Anthropometric and analytical parameters of phospho-calcium metabolism from 290 patients undergoing bariatric surgery were analyzed. The association between 25(OH)D and PTH before and 1 year after surgery was evaluated through Student's t test and simple and multivariable linear regression. RESULTS: At baseline, there was an inverse association between 25(OH)D and PTH plasma levels (β = - 0.571; p = 0.001). The threshold for a significant increase of PTH at baseline was a 25(OH)D level of < 10 ng/mL (p < 0.001). At 1 year after surgery (n = 194), the association between the two variables was weaker (β = - 0.291; p = 0.014). The 25(OH)D threshold for a significant increase in serum PTH levels was lower in patients who maintained obesity (n = 77) [25(OH)D 5 vs 10 ng/mL]. CONCLUSIONS: PTH suppression threshold observed in patients with morbid obesity before and after bariatric surgery is lower than that described for the general population, suggesting that the 25(OH)D plasma levels may not be representative of the body's vitamin D reserves. Other studies are required to demonstrate which optimal vitamin D levels need to be aimed for in obesity, in order to improve obese patients' bone health.
BACKGROUND: Serum 25-hydroxyvitamin D [25(OH)D] and parathormone (PTH) have an inverse relation. The 25(OH)D threshold required to maximally suppress PTH has been used as a marker of optimal vitamin D status. Obesity is associated with lower serum levels of 25(OH)D and higher levels of PTH; however, the relation between these hormones in this setting is not well established. We aimed to assess the influence of excessive weight and weight loss after bariatric surgery on the relation between serum 25(OH)D and PTH. METHODS: Anthropometric and analytical parameters of phospho-calcium metabolism from 290 patients undergoing bariatric surgery were analyzed. The association between 25(OH)D and PTH before and 1 year after surgery was evaluated through Student's t test and simple and multivariable linear regression. RESULTS: At baseline, there was an inverse association between 25(OH)D and PTH plasma levels (β = - 0.571; p = 0.001). The threshold for a significant increase of PTH at baseline was a 25(OH)D level of < 10 ng/mL (p < 0.001). At 1 year after surgery (n = 194), the association between the two variables was weaker (β = - 0.291; p = 0.014). The 25(OH)D threshold for a significant increase in serum PTH levels was lower in patients who maintained obesity (n = 77) [25(OH)D 5 vs 10 ng/mL]. CONCLUSIONS:PTH suppression threshold observed in patients with morbid obesity before and after bariatric surgery is lower than that described for the general population, suggesting that the 25(OH)D plasma levels may not be representative of the body's vitamin D reserves. Other studies are required to demonstrate which optimal vitamin D levels need to be aimed for in obesity, in order to improve obesepatients' bone health.
Authors: Kathleen M Hill; George P McCabe; Linda D McCabe; Catherine M Gordon; Steven A Abrams; Connie M Weaver Journal: J Nutr Date: 2010-09-22 Impact factor: 4.798
Authors: Sue A Shapses; Esther J Lee; Deeptha Sukumar; Ramon Durazo-Arvizu; Stephen H Schneider Journal: J Clin Endocrinol Metab Date: 2013-03-18 Impact factor: 5.958
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Greta Snellman; Håkan Melhus; Rolf Gedeborg; Liisa Byberg; Lars Berglund; Lisa Wernroth; Karl Michaëlsson Journal: PLoS One Date: 2010-07-13 Impact factor: 3.240
Authors: Karani S Vimaleswaran; Diane J Berry; Chen Lu; Emmi Tikkanen; Stefan Pilz; Linda T Hiraki; Jason D Cooper; Zari Dastani; Rui Li; Denise K Houston; Andrew R Wood; Karl Michaëlsson; Liesbeth Vandenput; Lina Zgaga; Laura M Yerges-Armstrong; Mark I McCarthy; Josée Dupuis; Marika Kaakinen; Marcus E Kleber; Karen Jameson; Nigel Arden; Olli Raitakari; Jorma Viikari; Kurt K Lohman; Luigi Ferrucci; Håkan Melhus; Erik Ingelsson; Liisa Byberg; Lars Lind; Mattias Lorentzon; Veikko Salomaa; Harry Campbell; Malcolm Dunlop; Braxton D Mitchell; Karl-Heinz Herzig; Anneli Pouta; Anna-Liisa Hartikainen; Elizabeth A Streeten; Evropi Theodoratou; Antti Jula; Nicholas J Wareham; Claes Ohlsson; Timothy M Frayling; Stephen B Kritchevsky; Timothy D Spector; J Brent Richards; Terho Lehtimäki; Willem H Ouwehand; Peter Kraft; Cyrus Cooper; Winfried März; Chris Power; Ruth J F Loos; Thomas J Wang; Marjo-Riitta Järvelin; John C Whittaker; Aroon D Hingorani; Elina Hyppönen Journal: PLoS Med Date: 2013-02-05 Impact factor: 11.069